The Food and Drug Administration is advising consumers not to purchase or use “Feng Shi Ling,” a product promoted and sold as an herbal medication for arthritic pain associated with rheumatoid arthritis and osteoporosis.

The U.S. Food and Drug Administration today approved Otezla (apremilast) to treat adults with active psoriatic arthritis (PsA).

The US Food and Drug Administration approved Xeljanz ( tofacitinib ) to treat adults with moderately to severely active rheumatoid arthritis (RA) who have had an inadequate response to, or who are intolerant of, methotrexate .

A team of researchers led by the U.S. Food and Drug Administration has discovered a new mechanism for identifying and understanding drug-related autoimmune reactions.

Pfizer Inc. announced that the Arthritis Advisory Committee to the U.S. Food and Drug Administration (FDA) voted 8-2 to recommend approval of the investigational agent tofacitinib for the treatment of adult patients with moderately to severely active rheumatoid arthritis (RA).

The FDA has a approved a new drug to treat systemic juvenile idiopathic arthritis - a rare type of arthritis but the most common form affecting children.

It has been more than half a century since the FDA last approved any drugs to treat lupus. Now there's a new medication going to market.